This is an annual conference organized by European Foundation for Clinical Nanomedicine (CLINAM). Dr. Patrick Lu, President and CSO of Sirnaomics, Inc., was invited by the organizing committee to speak in a platinum session “Peptide-Based Nanoparticles for Targeted Delivery of siRNA”.
Sirnaomics announced today that the company has made a major breakthrough in its novel small interfering RNA (siRNA) therapeutic product against human papillomavirus (HPV) infection and cervical cancer.
Sirnaomics could begin phase I testing of its siRNA-based wound-healing drug candidate STP-705 as soon as next year and expects to run the trial in China.
Sirnaomics announced today that the company has been awarded another NIH SBIR (Small Business Innovation Research) grant for developing its small interfering RNA (siRNA) therapeutic product STP705 to improve skin wound healing with minimized scar formation.
The 4th AsiaTIDES annuel conference, being held in Tokyo, Japan from February 28 to March 1, 2012, continues to be the premier forum to get a comprehensive update, meet key players and increase knowledge of the oligonucleotide- and peptide-based therapeutics fields.
Governor Martin O’Malley today announced appointments to the Maryland Council for Educator Effectiveness; the University System of Maryland Board of Regents; the Blue Ribbon Commission on Transportation Funding.